2,142 results on '"Scoazec, Jean Yves"'
Search Results
2. The genomic and transcriptomic landscape of metastastic urothelial cancer
3. Deciphering resistance mechanisms in cancer: final report of MATCH-R study with a focus on molecular drivers and PDX development
4. Molecular profiling of biliary tract cancers reveals distinct genomic landscapes between circulating and tissue tumor DNA
5. Uterine adenosarcoma: Clinical significance of histological classification and SNP array analysis
6. Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer
7. Immune checkpoints are predominantly co-expressed by clonally expanded CD4+FoxP3+ intratumoral T-cells in primary human cancers
8. A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors
9. Weakly supervised pan-cancer segmentation tool
10. Immunodetection of NUT Protein: Implementation, Indications, and Results in a Tertiary Reference Center
11. The search for therapeutic targets in lung cancer: Preclinical and human studies of carcinoembryonic antigen-related cell adhesion molecule 5 expression and its associated molecular landscape
12. Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma
13. Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data
14. Standardized Pathology Screening of Mature Tertiary Lymphoid Structures in Cancers
15. Ileal Neuroendocrine Neoplasms
16. Molecular analysis for refractory rare cancers: Sequencing battle continues – learnings for the MOSCATO-01 study
17. Neuropilin-1 cooperates with PD-1 in CD8+ T cells predicting outcomes in melanoma patients treated with anti-PD1
18. Sympathetic axonal sprouting induces changes in macrophage populations and protects against pancreatic cancer
19. De novo generation of the NPM-ALK fusion recapitulates the pleiotropic phenotypes of ALK+ ALCL pathogenesis and reveals the ROR2 receptor as target for tumor cells
20. TWIST1 expression is associated with high-risk neuroblastoma and promotes primary and metastatic tumor growth
21. Diagnostic Pitfall: a Low-Grade EC-Cell Neuroendocrine Tumor Arising in a Rectal Duplication Cyst
22. Prognostic value of tumor immune biomarkers in biopsies from patients with refractory solid cancers
23. B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors
24. Multifocal in situ mantle cell neoplasia of the ileocecal region: a case report with simultaneous nodal and extranodal involvement
25. Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence
26. Exceptional Response to Dual Colony-Stimulating Factor 1 Receptor/PD-L1 Targeting After Primary Resistance to PD-1 Inhibition in a Patient With a Metastatic Uveal Melanoma
27. FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin
28. Impact of expert review of histological diagnosis of papillary and follicular thyroid cancer
29. Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients
30. Histological classification of mucinous ovarian tumors: inter-observer reproducibility, clinical relevance, and role of genetic biomarkers
31. Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites
32. CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17
33. Le Conseil national professionnel d’anatomie et cytologie pathologiques (CNPath) : une structure au service de la profession
34. Syndromes de prédisposition aux tumeurs neuroendocrines gastro-entéro-pancréatiques et thoraciques
35. Updated Morphological and Immunohistochemical Profile of Neuroendocrine Tumors Developed in Ovarian Teratomas: A Large Series of a Rare and Heterogeneous Disease
36. Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common HLA-B and TAP transcriptional silencing across advanced pediatric solid cancers
37. Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort
38. Drug-induced bile duct injury: new agents, new mechanisms
39. Posttransplant immune-mediated cholangiopathies
40. Colon Cancer Metastasis Within a NIFTP: A Case Report and Review of the Literature
41. Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer
42. Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours
43. A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer
44. Weakly Supervised Pan-Cancer Segmentation Tool
45. Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors
46. Lung and digestive neuroendocrine neoplasms. From WHO classification to biomarker screening: Which perspectives?
47. O6-methylguanine-DNA methyltransferase (MGMT) status in neuroendocrine tumors: a randomized phase II study (MGMT-NET)
48. Influence of tumor-associated macrophages and HLA class I expression according to HPV status in head and neck cancer patients receiving chemo/bioradiotherapy
49. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
50. Dual alcohol and metabolic‐related liver disease: Results from a population of liver transplant patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.